Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement
Abstract This Consensus Statement from an international, multidisciplinary workshop
sponsored by the Pituitary Society offers evidence-based graded consensus …
sponsored by the Pituitary Society offers evidence-based graded consensus …
Clinical biology of the pituitary adenoma
All endocrine glands are susceptible to neoplastic growth, yet the health consequences of
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …
Diagnosis and treatment of pituitary adenomas: a review
Importance Pituitary adenomas may hypersecrete hormones or cause mass effects.
Therefore, early diagnosis and treatment are important. Observations Prevalence of pituitary …
Therefore, early diagnosis and treatment are important. Observations Prevalence of pituitary …
COVID-19 and the pituitary
Background Despite COVID-19 being identified as severe respiratory viral infection,
progressively many relevant endocrine manifestations have been reported greatly …
progressively many relevant endocrine manifestations have been reported greatly …
Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement
Introduction With the goal of generate uniform criteria among centers dealing with pituitary
tumors and to enhance patient care, the Pituitary Society decided to generate criteria for …
tumors and to enhance patient care, the Pituitary Society decided to generate criteria for …
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline
abstract Objective: The aim was to formulate practice guidelines for the diagnosis and
treatment of hyperprolactinemia. Participants: The Task Force consisted of Endocrine …
treatment of hyperprolactinemia. Participants: The Task Force consisted of Endocrine …
The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new
Prevalence and incidence of prolactinomas are approximately 50 per 100,000 and 3–5 new
cases/100,000/year. The pathophysiological mechanism of hyperprolactinemia-induced …
cases/100,000/year. The pathophysiological mechanism of hyperprolactinemia-induced …
The incidence rate of pituitary adenomas in western Sweden for the period 2001–2011
A Tjörnstrand, K Gunnarsson, M Evert… - European journal of …, 2014 - academic.oup.com
Objective The number of studies on the incidence of pituitary adenomas (PAs) is limited. The
aim of this study was to evaluate the standardised incidence rate (SIR) of PAs in western …
aim of this study was to evaluate the standardised incidence rate (SIR) of PAs in western …
Hyperprolactinaemia
I Samperi, K Lithgow, N Karavitaki - Journal of clinical medicine, 2019 - mdpi.com
Hyperprolactinaemia is one of the most common problems in clinical endocrinology. It
relates with various aetiologies (physiological, pharmacological, pathological), the …
relates with various aetiologies (physiological, pharmacological, pathological), the …
Pituitary incidentaloma: an endocrine society clinical practice guideline
Objective: The aim was to formulate practice guidelines for endocrine evaluation and
treatment of pituitary incidentalomas. Consensus Process: Consensus was guided by …
treatment of pituitary incidentalomas. Consensus Process: Consensus was guided by …